Combining weight loss medications increases the risk of side effects and is absolutely not suitable for everyone
High expression of NLRP3, GSDMD, caspase-1, IL-18, and IL-1 has been observed in ovarian tissues of POI animal models (Khallaf et al., 2023
By improving metabolic fitness before overt disease emerges, GLP-1 therapies prevent a wide range of complications
Still, a lot of people don't want to take an injectable medication, said Dr
It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants, and people with severe obesity on the highest dose lost on average 30% of their body weight over two years, lead investigator Ania Jastreboff, MD, professor of medicine and pediatrics at the Yale School of Medicine and director of the Yale Obesity Research Center, said in a press release
Semaglutide works by slowing stomach emptying and activating appetite-control centers in the brain, leading most patients to eat between 1,200 and 1,800 calories daily without deliberate calorie counting